176 related articles for article (PubMed ID: 24131750)
21. Imaging characteristics of atypical teratoid-rhabdoid tumor in children compared with medulloblastoma.
Koral K; Gargan L; Bowers DC; Gimi B; Timmons CF; Weprin B; Rollins NK
AJR Am J Roentgenol; 2008 Mar; 190(3):809-14. PubMed ID: 18287456
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of medulloblastoma in children under age of three years.
Ryzhova MV; Zheludkova OG; Kumirova ÉV; Shishkina LV; Panina TN; Gorelyshev SK; Khukhlaeva EA; Mazerkina NA; Matuev KB; Medvedeva OA; Tarasova EM; Kholodov BV; Kapitul'skaia OIu
Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(1):3-10; discussion 11. PubMed ID: 23659115
[TBL] [Abstract][Full Text] [Related]
23. Oncogene amplification in medulloblastoma: analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization.
Jay V; Squire J; Bayani J; Alkhani AM; Rutka JT; Zielenska M
Pathology; 1999 Nov; 31(4):337-44. PubMed ID: 10643003
[TBL] [Abstract][Full Text] [Related]
24. Medullomyoblastoma with calcification: a case report.
Chaturvedi S; Gupta S; Singhal S; Kumari R
Neuropathology; 2008 Feb; 28(1):93-7. PubMed ID: 18181837
[TBL] [Abstract][Full Text] [Related]
25. Correlation of gamma-catenin expression with good prognosis in medulloblastomas.
Misaki K; Marukawa K; Hayashi Y; Fukusato T; Minamoto T; Hasegawa M; Yamashita J; Fujisawa H
J Neurosurg; 2005 Mar; 102(2 Suppl):197-206. PubMed ID: 16156230
[TBL] [Abstract][Full Text] [Related]
26. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.
Aldosari N; Bigner SH; Burger PC; Becker L; Kepner JL; Friedman HS; McLendon RE
Arch Pathol Lab Med; 2002 May; 126(5):540-4. PubMed ID: 11958658
[TBL] [Abstract][Full Text] [Related]
27. Medulloblastoma in a child with Duchenne muscular dystrophy.
Doddihal H; Jalali R
Childs Nerv Syst; 2007 May; 23(5):595-7. PubMed ID: 17187273
[TBL] [Abstract][Full Text] [Related]
28. WNT-activated medulloblastoma with melanotic and myogenic differentiation: Report of a rare case.
Rajeshwari M; Kakkar A; Nalwa A; Suri V; Sarkar C; Satyarthee GD; Garg A; Sharma MC
Neuropathology; 2016 Aug; 36(4):372-5. PubMed ID: 26869281
[TBL] [Abstract][Full Text] [Related]
29. Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours.
Goschzik T; Zur Mühlen A; Kristiansen G; Haberler C; Stefanits H; Friedrich C; von Hoff K; Rutkowski S; Pfister SM; Pietsch T
Neuropathol Appl Neurobiol; 2015 Feb; 41(2):135-44. PubMed ID: 24894640
[TBL] [Abstract][Full Text] [Related]
30. Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients.
Lamont JM; McManamy CS; Pearson AD; Clifford SC; Ellison DW
Clin Cancer Res; 2004 Aug; 10(16):5482-93. PubMed ID: 15328187
[TBL] [Abstract][Full Text] [Related]
31. Beta-catenin status in paediatric medulloblastomas: correlation of immunohistochemical expression with mutational status, genetic profiles, and clinical characteristics.
Fattet S; Haberler C; Legoix P; Varlet P; Lellouch-Tubiana A; Lair S; Manie E; Raquin MA; Bours D; Carpentier S; Barillot E; Grill J; Doz F; Puget S; Janoueix-Lerosey I; Delattre O
J Pathol; 2009 May; 218(1):86-94. PubMed ID: 19197950
[TBL] [Abstract][Full Text] [Related]
32. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
33. Cytogenetic and molecular biological characterization of an adult medulloblastoma.
Holland H; Koschny R; Krupp W; Meixensberger J; Bauer M; Schober R; Kirsten H; Ganten TM; Ahnert P
Cancer Genet Cytogenet; 2007 Oct; 178(2):104-13. PubMed ID: 17954265
[TBL] [Abstract][Full Text] [Related]
34. Alpha-internexin expression in medulloblastomas and atypical teratoid-rhabdoid tumors.
Kaya B; Mena H; Miettinen M; Rushing EJ
Clin Neuropathol; 2003; 22(5):215-21. PubMed ID: 14531545
[TBL] [Abstract][Full Text] [Related]
35. [Medullomyoblastoma: a medulloblastoma with rhabdomyoblastic differentiation].
Gauchotte G; Baylac F; Marie B; Vignaud JM
Ann Pathol; 2010 Apr; 30(2):135-8. PubMed ID: 20451073
[TBL] [Abstract][Full Text] [Related]
36. Importance of re-examination for medulloblastoma and atypical teratoid/rhabdoid tumor.
Utsuki S; Oka H; Tanaka S; Kondo K; Tanizaki Y; Fujii K
Acta Neurochir (Wien); 2003 Aug; 145(8):663-6; discussion 666. PubMed ID: 14520545
[TBL] [Abstract][Full Text] [Related]
37. Loss of heterozygosity and p53 polymorphism Pro72Arg in a young patient with medulloblastoma.
Sardi I; Giunti L; Donati P; Lacitignola L; Tucci F; Sardo L; Giovannucci Uzielli ML; Bernini G
Oncol Rep; 2003; 10(3):773-5. PubMed ID: 12684657
[TBL] [Abstract][Full Text] [Related]
38. [A case of medullomyoblastoma].
Aramaki Y; Shimokawa S; Nakashima S; Nakamura Y
No Shinkei Geka; 2011 Nov; 39(11):1073-7. PubMed ID: 22036819
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical and proteomic profile of melanotic medulloblastoma.
Zanini C; Mandili G; Pulerà F; Morra I; Peretta P; Turrini F; Forni M
Pediatr Blood Cancer; 2009 Jul; 52(7):875-7. PubMed ID: 19061219
[TBL] [Abstract][Full Text] [Related]
40. Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations.
Gururangan S; Robinson G; Ellison DW; Wu G; He X; Lu QR; McLendon R; Grant G; Driscoll T; Neuberg R
Pediatr Blood Cancer; 2015 Oct; 62(10):1855-8. PubMed ID: 25940061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
